Belgian FM signs medical research cooperation agreement with Hadassah

The agreement covers the fields of healthcare, medical education, clinical research and hospital management.

November 13, 2013 00:41
1 minute read.
The new tower in Hadassah Hospital.

New tower in Hadassah Hospital 370. (photo credit: Judy Siegel-Itzkovich)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

A collaboration agreement in the fields of healthcare, medical education, clinical research and hospital management was signed on Tuesday between the Hadassah Medical Organization (HMO) and the Jules Bordet Institute in Brussels – Belgium’s only hospital dealing exclusively with cancer.

Joint research with Hadassah has already begun in breast cancer and pediatric oncology. Other fields are to follow soon.

Be the first to know - Join our Facebook page.

Present at the Jerusalem ceremony was Didier Reynders, Belgium’s foreign minister and deputy prime minister.

Representing HMO was its deputy director for research, Prof. Yaakov Naparstek.

“In signing business agreements, there’s always the feeling that one side is getting more than the other,” said Naparstek. “In contrast, when you sign an agreement to share information, you both enjoy the growing reservoir of knowledge.”

Reynders called it a “very emotional moment.”

“There isn’t a more meaningful way to cooperate than treating breast cancer and cancer in children,” he said.

“Hadassah is also a bridge for peace. Working together, these two great hospitals are finding ways to add to the betterment of humanity.”

Speaking for the Jules Bordet Institute, Prof. Maurice Sosnowski – who is both head of its anesthesiology department and president of Hadassah International, Belgium – said: “Joint science and research is proof that the stupidity of hatred contributes nothing to humankind, but cooperation and life-saving medicine will save the world.”

The ceremony took place in the Abbell Synagogue, home of the Chagall windows, at Hadassah University Medical Center in Ein Kerem.

The delegation toured the hospital’s hemo-oncology ward and laboratories for gene therapy.

An agreement on research cooperation in giving medications to children was also signed Tuesday by the Hebrew University’s School of Pharmacy and Drexel University and Children’s Hospital of Philadelphia. It took place in Jerusalem Mayor Nir Barkat’s office at City Hall and was attended by Michael Nutter, mayor of Philadelphia.

Related Content

August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice